Showing results (101-110 of 236) with videos related to
Sort By:
Pageof 24
Viruses|August 10, 2021
Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort StudyMartina Spaziante, Gloria Taliani, Giulia Marchetti, et al.Archives of Internal Medicine|October 11, 2002
Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjectsAndrea De Luca, Roberto Bugarini, Alessandro Cozzi Lepri, et al.Antiviral Therapy|July 22, 2006
Influence of hepatitis C genotypes on lipid levels in HIV-positive patients during highly active antiretroviral therapyGiuseppe Lapadula, Carlo Torti, Giuseppe Paraninfo, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 1, 2022
Similar survival but higher and delayed hepatocellular carcinoma recurrence in HIV-positive compared to negative cirrhotics undergoing liver transplantationRoberto Rossotti, Marco Merli, Chiara Mazzarelli, et al.Journal of Viral Hepatitis|February 26, 2019
The impact of HIV infection and men who have sex with men status on hepatitis A infection: The experience of two tertiary centres in Northern Italy during the 2017 outbreak and in the 2009-2016 periodAndrea Lombardi, Roberto Rossotti, Maria Cristina Moioli, et al.Journal of Hepatology|November 10, 2012
Clinical management of drug-drug interactions in HCV therapy: challenges and solutionsDavid Burger, David Back, Peter Buggisch, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 24, 2019
Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort StudySebastiano Leone, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.BMC Research Notes|April 19, 2013
Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in ItalyGiorgio Antonucci, Francesco Mazzotta, Claudio Angeletti, et al.Antiviral Therapy|October 1, 2004
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation?Massimo Puoti, Sergio Babudieri, Giovanni Rezza, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 6, 2025
Long-term trajectories of hepatic and metabolic biomarkers after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral therapy-experienced people with HIV with and without hepatic coinfection: Data from the ICONA cohortMariacristina Poliseno, Sergio Lo Caputo, Alessandro Tavelli, et al.Pageof 24